Literature DB >> 22494877

Health and quality of life in adults with Noonan syndrome.

Gerhard Binder1, Sabrina Grathwol, Karoline von Loeper, Gunnar Blumenstock, Renate Kaulitz, Clemens Freiberg, Martin Webel, Christina Lissewski, Martin Zenker, Thomas Paul.   

Abstract

OBJECTIVE: To obtain information on health and quality of life in adults with Noonan syndrome. STUDY
DESIGN: From a cohort of 144 children with the diagnosis of Noonan syndrome whose height data had been published 23 years ago, 103 pediatric files providing adequate data were identified. Participants were sent questionnaires and asked to provide saliva for DNA analysis and to return for physical examination.
RESULTS: Ten of 103 individuals had died, 3 of them suddenly (standardized mortality ratio, 3.00; 95% CI, 1.44-5.52). Eighty-one individuals could be contacted by mail, with a positive response from 45. Genotyping in 36 of 45 participants revealed characteristic mutations in 61%. Median age at follow-up was 42.8 years. Mean adult heights were 169.2 cm (men) and 154.4 cm (women). In comparison with the general population, participants had lower educational status and lived more frequently without any partner. According to the response to the Short Form-36 questionnaire, quality of life was not impaired.
CONCLUSIONS: Individuals with Noonan syndrome have higher mortality, lower education, and rarely partnership. Quality of life according to self-reported Short Form-36 was good. Men grew taller than previously reported from this cohort.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22494877     DOI: 10.1016/j.jpeds.2012.02.043

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Do you know this syndrome? Noonan syndrome.

Authors:  Rogerio Nabor Kondo; Ligia Márcia Mario Martins; Vivian Cristina Holanda Lopes; Rodrigo Antonio Bittar; Fernanda Mendes Araújo
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

2.  LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity.

Authors:  Mylène Tajan; Aurélie Batut; Thomas Cadoudal; Simon Deleruyelle; Sophie Le Gonidec; Céline Saint Laurent; Maëlle Vomscheid; Estelle Wanecq; Karine Tréguer; Audrey De Rocca Serra-Nédélec; Claire Vinel; Marie-Adeline Marques; Joffrey Pozzo; Oksana Kunduzova; Jean-Pierre Salles; Maithé Tauber; Patrick Raynal; Hélène Cavé; Thomas Edouard; Philippe Valet; Armelle Yart
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

3.  Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.

Authors:  Ichiro Kawashima; Naoki Oishi; Kazunari Kasai; Tomohiro Inoue; Eriko Hosokawa; Ayato Nakadate; Minori Matsuura; Takuma Kumagai; Megumi Koshiishi; Takeo Yamamoto; Kei Nakajima; Masaru Tanaka; Tetsuo Kondo; Keita Kirito
Journal:  Virchows Arch       Date:  2021-07-06       Impact factor: 4.064

4.  Haploinsufficiency of the NF1 gene is associated with protection against diabetes.

Authors:  Roope A Kallionpää; Sirkku Peltonen; Jussi Leppävirta; Minna Pöyhönen; Kari Auranen; Hannu Järveläinen; Juha Peltonen
Journal:  J Med Genet       Date:  2020-06-22       Impact factor: 6.318

5.  Growth references for Japanese individuals with Noonan syndrome.

Authors:  Tsuyoshi Isojima; Satoru Sakazume; Tomonobu Hasegawa; Tsutomu Ogata; Toshio Nakanishi; Toshiro Nagai; Susumu Yokoya
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.953

6.  Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program.

Authors:  Peter A Lee; Judith L Ross; Birgitte Tønnes Pedersen; Primoz Kotnik; John A Germak; Henrik T Christesen
Journal:  Int J Pediatr Endocrinol       Date:  2015-09-08

7.  Noonan syndrome - a new survey.

Authors:  Alireza Tafazoli; Peyman Eshraghi; Zahra Kamel Koleti; Mohammadreza Abbaszadegan
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

8.  Personality and Psychopathology in Adults with Noonan Syndrome.

Authors:  Renée L Roelofs; Ellen Wingbermühle; Paul T van der Heijden; Rosella Jonkers; Marieke de Haan; Roy P C Kessels; Jos I M Egger
Journal:  J Clin Psychol Med Settings       Date:  2020-06

9.  Validation of auxological reference values for Japanese children with Noonan syndrome and comparison with growth in children with Turner syndrome.

Authors:  Tsuyoshi Isojima; Satoru Sakazume; Tomonobu Hasegawa; Tsutomu Ogata; Toshio Nakanishi; Toshiro Nagai; Susumu Yokoya
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

10.  Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study.

Authors:  Louise Jayne Apperley; Renuka Ramakrishnan; Poonam Dharmaraj; Urmi Das; Mohammed Didi; Jo Blair; Senthil Senniappan
Journal:  Int J Endocrinol Metab       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.